27 results
8-K
EX-99.1
DAWN
Day One Biopharmaceuticals Inc
26 Feb 24
Day One Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Progress
4:30pm
for the year ended December 31, 2022, with non-cash stock compensation expense of $27.2 million.
Upcoming Events
44th Annual TD Cowen Health Care Conference
8-K
EX-1.1
2v3s1rf6yx1z9skg
7 Jun 23
Day One Announces Pricing of Public Offering of Common Stock
5:00pm
PRE 14A
85bq46xxabbfek7u
18 Apr 23
Preliminary proxy
4:05pm
8-K
EX-1.1
4ebtj42lap7vp9
16 Jun 22
Day One Announces Pricing of Upsized Public Offering of Common Stock
7:33am
S-3
EX-1.2
snm3a 3enu
1 Jun 22
Shelf registration
4:06pm
DEF 14A
ouzi3a bdm
28 Apr 22
Definitive proxy
4:44pm
10-K
xq57igqv 727qv7d
7 Mar 22
Annual report
7:36am
8-K
EX-99.1
cjk9n xsj8
7 Mar 22
Day One Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Progress
7:30am
10-Q
y7rwovzf3crb84sehd
10 Aug 21
Quarterly report
5:26pm
424B4
lo00h
27 May 21
Prospectus supplement with pricing info
4:18pm